1. Home
  2. LUNR vs VRDN Comparison

LUNR vs VRDN Comparison

Compare LUNR & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$23.88

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$14.84

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUNR
VRDN
Founded
2013
2006
Country
United States
United States
Employees
525
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.7B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
LUNR
VRDN
Price
$23.88
$14.84
Analyst Decision
Buy
Strong Buy
Analyst Count
9
14
Target Price
$20.83
$36.00
AVG Volume (30 Days)
14.0M
3.1M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,706,000.00
Revenue This Year
$342.04
$28.34
Revenue Next Year
$16.63
$235.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.75
$11.76
52 Week High
$25.00
$34.29

Technical Indicators

Market Signals
Indicator
LUNR
VRDN
Relative Strength Index (RSI) 60.92 24.11
Support Level $15.87 $14.76
Resistance Level N/A $18.57
Average True Range (ATR) 2.37 1.39
MACD 0.46 -0.94
Stochastic Oscillator 89.40 10.29

Price Performance

Historical Comparison
LUNR
VRDN

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space infrastructure and services company focused on enabling sustained human activity beyond Earth. It designs, builds, integrates, and operates space systems, offering infrastructure-as-a-service across low Earth orbit, geostationary orbit, cislunar space, and deep space. Its capabilities include spacecraft development and space-based network connectivity, serving commercial, civil, and national security customers. The company conducts sales both directly and through an extensive customer and partner network spanning North America, South America, Europe, Asia, and Australia, including rideshare delivery providers, lunar surface mobility providers, payload providers, communication satellite providers, and ground segment providers.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: